8-K/A XBRL

8-K/A

Company: CUMBERLAND PHARMACEUTICALS INC
Filed: March 17, 2022
Period of Report: March 17, 2022
Accession Number: 0001628280-22-006570

View Document ↗ View on SEC.gov ↗